Stock LNTH LANTHEUS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Lantheus Holdings, Inc.

Equities

LNTH

US5165441032

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
76.02 USD +0.16% Intraday chart for Lantheus Holdings, Inc. +0.65% +22.61%
May. 03 Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating MT
May. 02 Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised MT

Chart calendar Lantheus Holdings, Inc.

2b080078.59VrDhj3SgWYFuxiViNtb5n0XJmz_pVv1wDsKqA2kYQ.k5gtQU2UPnfiSaVPN0ooPvanMcnpy9IDs2_BeJZUpeWXuDJNUZwNQ_0giw~d96070a7e1f5930a124f84c15106b6fb

Upcoming events on Lantheus Holdings, Inc.

2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Lantheus Holdings, Inc.

2024-05-02 08:00 am Q1 2024 Earnings Call
2024-05-02 07:00 am Q1 2024 Earnings Release
2024-04-25 10:30 am Annual General Meeting
2024-03-12 09:20 am Leerink Partners Global Biopharma Conference
2024-03-04 10:30 am TD Cowen Health Care Conference
2024-02-22 08:00 am Q4 2023 Earnings Call
2024-02-22 07:00 am Q4 2023 Earnings Release
2024-01-10 02:15 pm JPMorgan Healthcare Conference
2023-11-15 03:00 am Jefferies London Healthcare Conference
2023-11-02 08:00 am Q3 2023 Earnings Call
2023-11-02 07:00 am Q3 2023 Earnings Release
2023-09-10 02:00 am European Association of Nuclear Medicine Meeting - Poster No - OP-041
2023-09-07 09:30 am Wells Fargo Healthcare Conference
2023-08-03 08:00 am Q2 2023 Earnings Call
2023-08-03 07:00 am Q2 2023 Earnings Release
2023-06-26 12:15 pm Society of Nuclear Medicine and Molecular Imaging Meeting - Poster Number: P837
2023-06-25 12:00 pm Society for Nuclear Medicine and Molecular Imaging Meeting - Poster Number: P228
2023-06-08 09:00 am Jefferies Global Healthcare Conference
2023-05-04 08:00 am Q1 2023 Earnings Call
2023-05-04 07:00 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		347
349
-0.43%		339
337
0.81%		425
407
4.37%		935
917
1.95%		1 296
1 284
0.99%
1 502

EBITDA
Million USD		Released
Forecast
Spread 		84,0
96,8
-13.3%		58,9
52,6
11.83%		99,7
74,4
34.02%		451
424
6.46%		606
593
2.21%
713

EBIT
Million USD		Released
Forecast
Spread 		72,4
70,1
3.28%		34,2
37,9
-9.72%		57,8
45,5
27.02%		403
381
5.83%		546
576
-5.2%
653

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		28,6
61,0
-53.07%		-11,5
0,00
- 		-75,0
-41,6
-80.38%		26,7
270
-90.12%		411
393
4.6%
534

Net income
Million USD		Released
Forecast
Spread 		31,7
45,0
-29.63%		-13,5
0,00
- 		-71,3
-11,5
-522.52%		28,1
200
-85.99%		327
313
4.49%
437

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-1,06
-0,50
-112%		0,40
2,82
-85.82%		4,65
4,45
4.42%
6,13

Announcement Date25/02/2025/02/2124/02/2223/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		209
165
26.36%		224
205
9.39%		239
228
5.01%		263
245
7.27%		301
281
7.17%		322
307
4.9%		320
314
1.76%		354
341
3.72%		370
349
5.95%
378


375


383


371


380

EBITDA
Million USD		Released
Forecast
Spread 		95,8
51,0
87.71%		91,9
75,0
22.51%		114
91,2
25.45%		132
110
19.86%		157
132
18.57%		166
153
8.68%		154
145
6.15%		181
151
19.35%		171
158
7.87%
184


180


191


181


188

EBIT
Million USD		Released
Forecast
Spread 		92,7
42,6
117.58%		88,6
68,6
29.17%		102
82,2
24.3%		120
97,6
23.26%		142
124
14.8%		150
132
13.4%		140
132
5.74%		166
144
15.2%		155
150
3.29%
168


163


173


155


161

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		57,9
44,4
30.41%		62,0
68,8
-9.82%		83,0
57,5
44.45%		-176
67,5
-361.24%		-11,1
-9,38
-18.39%		124
108
14.58%		160
101
58.61%		138
120
15.01%		171
105
63.11%
162


161


147


151


44,5

Net income
Million USD		Released
Forecast
Spread 		43,0
30,5
40.63%		43,1
43,1
-0.1%		61,2
43,3
41.55%		-119
52,8
-325.62%		-2,81
52,3
-105.37%		94,1
75,9
24%		132
76,3
72.93%		103
89,3
15.72%		131
82,9
58.05%
108


109


102


113


67,5

EPS
USD		Released
Forecast
Spread 		0,61
0,46
32.61%		0,61
0,70
-12.86%		0,86
0,54
60.75%		-1,74
0,70
-348.57%		-0,04
0,49
-108.25%		1,33
1,06
25.47%		1,88
1,08
74.07%		1,47
1,26
16.67%		1,87
1,17
60.17%
1,53


1,52


1,41


1,56


0,92

Announcement Date29/04/2204/08/2203/11/2223/02/2304/05/2303/08/2302/11/2322/02/2402/05/24-----

Upcoming sector events for Lantheus Holdings, Inc.

2024-05-12 SD BIOSENSOR, INC: Q1 2024 Earnings Release (Projected)
2024-07-17 02:00 am VITROLIFE AB: Q2 2024 Earnings Release
2024-07-29 AMOY DIAGNOSTICS CO., LTD.: Q2 2024 Earnings Release (Projected)
2024-07-31 MYRIAD GENETICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 LANTHEUS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 10X GENOMICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 MACCURA BIOTECHNOLOGY CO.LTD: Q2 2024 Earnings Release (Projected)
2024-07-31 SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release (Projected)
2024-07-31 DIASORIN S.P.A.: Q2 2024 Earnings Release
2024-08-04 CASTLE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Lantheus Holdings, Inc.

2024-05-09 DIASORIN S.P.A.: Q1 2024 Earnings Release
2024-05-07 04:05 pm MYRIAD GENETICS, INC.: Q1 2024 Earnings Release
2024-05-02 04:05 pm CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release
2024-05-02 07:00 am LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-30 04:05 pm 10X GENOMICS, INC.: Q1 2024 Earnings Release
2024-04-29 ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release
2024-04-29 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release
2024-04-29 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ZHEJIANG ORIENT GENE BIOTECH CO.,LTD: Q4 2023 Earnings Release
2024-04-29 CHEMCLIN DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LNTH Stock
  4. Calendar Lantheus Holdings, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW